Orthofix Medical Inc
NASDAQ:OFIX
Orthofix Medical Inc
Capital Expenditures
Orthofix Medical Inc
Capital Expenditures Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Capital Expenditures | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Orthofix Medical Inc
NASDAQ:OFIX
|
Capital Expenditures
-$34.6m
|
CAGR 3-Years
-12%
|
CAGR 5-Years
-7%
|
CAGR 10-Years
-2%
|
|
|
Boston Scientific Corp
NYSE:BSX
|
Capital Expenditures
-$876m
|
CAGR 3-Years
-14%
|
CAGR 5-Years
-11%
|
CAGR 10-Years
-5%
|
|
|
Edwards Lifesciences Corp
NYSE:EW
|
Capital Expenditures
-$260.2m
|
CAGR 3-Years
1%
|
CAGR 5-Years
9%
|
CAGR 10-Years
-9%
|
|
|
Stryker Corp
NYSE:SYK
|
Capital Expenditures
-$761m
|
CAGR 3-Years
-9%
|
CAGR 5-Years
-9%
|
CAGR 10-Years
-11%
|
|
|
Abbott Laboratories
NYSE:ABT
|
Capital Expenditures
-$2.2B
|
CAGR 3-Years
-7%
|
CAGR 5-Years
0%
|
CAGR 10-Years
-7%
|
|
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
Capital Expenditures
-$539.8m
|
CAGR 3-Years
0%
|
CAGR 5-Years
-10%
|
CAGR 10-Years
-21%
|
|
Orthofix Medical Inc
Glance View
Orthofix Medical, Inc. engages in the provision of medical devices. The company is headquartered in Lewisville, Texas and currently employs 1,087 full-time employees. The firm is focused on providing reconstructive and regenerative orthopedic and spine solutions to physicians. The firm has two reporting segments: Global Spine and Global Orthopedics. The Global spine segment provide three product categories such as Bone Growth Therapies, Spinal Implants, and Biologics. Its products also consist of bone growth therapies devices, motion preservation products, spine fixation products, and orthopedics products. The Global Orthopedics offers products and solutions that allow physicians to treat a variety of orthopedic conditions in adults and children unrelated to the spine. The company distribute its products globally to hospitals and health providers.
See Also
What is Orthofix Medical Inc's Capital Expenditures?
Capital Expenditures
-34.6m
USD
Based on the financial report for Dec 31, 2025, Orthofix Medical Inc's Capital Expenditures amounts to -34.6m USD.
What is Orthofix Medical Inc's Capital Expenditures growth rate?
Capital Expenditures CAGR 10Y
-2%
Over the last year, the Capital Expenditures growth was 1%. The average annual Capital Expenditures growth rates for Orthofix Medical Inc have been -12% over the past three years , -7% over the past five years , and -2% over the past ten years .
